CLAY B. MARSH, MD
Osteopathic Medicine at Kenny Rd, Columbus, OH
License number
Ohio 35058232
Category
Osteopathic Medicine
Type
Pulmonary Disease
License number
Ohio 35058232
Category
Osteopathic Medicine
Type
Critical Care Medicine
Address
Address
2050 Kenny Rd SUITE 2200, Columbus, OH 43221
Phone
(614) 293-4925
(614) 293-5503 (Fax)
(614) 947-3700
(614) 293-5503 (Fax)
(614) 947-3700
Personal information
See more information about CLAY B. MARSH at radaris.comName
Address
Phone
2266 Club Rd, Upper Arlington, OH 43221
3254 Jeffery Dr, Franklin, OH 45005
Columbus, OH
2266 Club Rd, Upper Arlington, OH 43221
2399 Kensington Dr, Columbus, OH 43221
Professional information
Dr. Clay B Marsh, Columbus OH - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
Meiling Hall
370 W 9Th Ave SUITE 2, Columbus 43210
(614) 292-2600 (Phone), (614) 292-4254 (Fax)
Martha Morehouse Medical Plaza
2050 Kenny Rd, Columbus 43221
(614) 293-5123 (Phone)
370 W 9Th Ave SUITE 2, Columbus 43210
(614) 292-2600 (Phone), (614) 292-4254 (Fax)
Martha Morehouse Medical Plaza
2050 Kenny Rd, Columbus 43221
(614) 293-5123 (Phone)
Certifications:
Critical Care Medicine, Internal Medicine, Pulmonary Disease, 2002, Pulmonology
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Meiling Hall
370 W 9Th Ave SUITE 2, Columbus 43210
Martha Morehouse Medical Plaza
2050 Kenny Rd, Columbus 43221
The Ohio State University Hospital East
1492 East Broad St, Columbus 43205
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
370 W 9Th Ave SUITE 2, Columbus 43210
Martha Morehouse Medical Plaza
2050 Kenny Rd, Columbus 43221
The Ohio State University Hospital East
1492 East Broad St, Columbus 43205
Wexner Medical Center at The Ohio State University
410 West 10Th Ave, Columbus 43210
Education:
Medical School
W Va University School Med
Graduated: 1985
Ohio State University Med Center
Graduated: 1986
Graduated: 1988
Graduated: 1992
W Va University School Med
Graduated: 1985
Ohio State University Med Center
Graduated: 1986
Graduated: 1988
Graduated: 1992
Affiliations:
Ohio State's Wexner Medical Center, Chief Innovation Officer
The Ohio State University College of Medicine
Clay B Marsh, Columbus OH
Specialties:
Pulmonologist
Address:
700 Ackerman Rd, Columbus, OH 43202
Education:
West Virginia University, School of Medicine - Doctor of Medicine*
Ohio State University Medical Center, The - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)*
Ohio State University Medical Center, The - Residency - Internal Medicine*
Ohio State University Medical Center, The - Internship - Internal Medicine*
Ohio State University Medical Center, The - Fellowship - Pulmonary Disease and Critical Care Medicine (Internal Medicine)*
Ohio State University Medical Center, The - Residency - Internal Medicine*
Ohio State University Medical Center, The - Internship - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine)*
Microrna Expression Profiling And Targeting In Peripheral Blood In Lung Cancer
US Patent:
2010032, Dec 23, 2010
Filed:
Nov 26, 2008
Appl. No.:
12/745327
Inventors:
Serge P. Nana-Sinkam - Columbus OH, US
Clay B. Marsh - Columbus OH, US
Melissa G. Piper - Dublin OH, US
Gregory A. Otterson - Upper Arlington OH, US
Clay B. Marsh - Columbus OH, US
Melissa G. Piper - Dublin OH, US
Gregory A. Otterson - Upper Arlington OH, US
Assignee:
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION - Columbus OH
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
A method for the diagnosis, prognosis and treatment of lung cancer by detecting at least one microRNA in peripheral blood is disclosed.
Methods, Compositions, And Devices Utilizing Microrna To Determine Physiological Conditions
US Patent:
2010021, Aug 26, 2010
Filed:
Nov 10, 2009
Appl. No.:
12/615969
Inventors:
David Galas - Seattle WA, US
Richard Evan Gelinas - Seattle WA, US
Clay Braden Marsh - Columbus OH, US
Melissa Garnet Piper - Dublin OH, US
Kai Wang - Bellevue OH, US
Shile Zhang - Seattle WA, US
Richard Evan Gelinas - Seattle WA, US
Clay Braden Marsh - Columbus OH, US
Melissa Garnet Piper - Dublin OH, US
Kai Wang - Bellevue OH, US
Shile Zhang - Seattle WA, US
Assignee:
BATTELLE MEMORIAL INSTITUTE - Columbus OH
INSTITUTE FOR SYSTEMS BIOLOGY - Seattle WA
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION - Columbus OH
INSTITUTE FOR SYSTEMS BIOLOGY - Seattle WA
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION - Columbus OH
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Methods, compositions, and devices are disclosed which use microRNA to detect, predict, treat, and monitor physiological conditions such as disease or injury. microRNA are isolated and their differential expression is measured to provide diagnostic information. This information may then be utilized for evaluation and/or treatment purposes.
Methods And Reagents For Treating Inflammation And Fibrosis
US Patent:
2007012, May 31, 2007
Filed:
Dec 19, 2006
Appl. No.:
11/613070
Inventors:
Clay Marsh - Columbus OH, US
Charles Orosz - Columbus OH, US
Charles Orosz - Columbus OH, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
A61K 38/17, A61K 48/00
US Classification:
514012000, 514044000
Abstract:
Methods are provided for providing anti-inflammatory activity and inhibiting a fibrotic disease, such as pulmonary fibrosis, in an individual. The methods comprise administering a biologically effective amount of latency-associated peptide (LAP) to the individual. Also provided are pharmaceutical compositions comprising LAP for use in accordance with these methods.
Methods For Stabilizing Hypoxia Inducible Factor-2 Alpha As A Method For Treating Cancer
US Patent:
2012032, Dec 27, 2012
Filed:
Jun 5, 2012
Appl. No.:
13/489387
Inventors:
Clay B. Marsh - Columbus OH, US
Timothy Darren Eubank - Columbus OH, US
Julie Michelle Rhoda - Columbus OH, US
Joseph H. Gardner - Cincinnati OH, US
Robert Shalwitz - Bexley OH, US
Timothy Darren Eubank - Columbus OH, US
Julie Michelle Rhoda - Columbus OH, US
Joseph H. Gardner - Cincinnati OH, US
Robert Shalwitz - Bexley OH, US
Assignee:
The Ohio State University - Columbus OH
International Classification:
A61K 31/4412, C12N 5/09, C12N 5/071, A61P 35/00, A61P 35/02
US Classification:
514350, 435375
Abstract:
Disclosed herein is {[5-(3-fluorophenyl)-3-hydroxypyridine-2-carbonyl]-amino}acetic acid and the ester and amide prodrugs thereof, that can stabilize hypoxia inducible factor-2 alpha (HIF-2α) and thereby provide a method for treating cancer. Further disclosed are compositions which comprise {[5-(3-fluorophenyl)-3-hydroxypyridine-2-carbonyl]-amino}acetic acid and/or a prodrug thereof which can be used to treat cancer.
Methods And Reagents For Treating Inflammation And Fibrosis
US Patent:
2005016, Jul 28, 2005
Filed:
Jul 16, 2004
Appl. No.:
10/892997
Inventors:
Clay Marsh - Columbus OH, US
Charles Orosz - Columbus OH, US
Charles Orosz - Columbus OH, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
A61K038/17
US Classification:
514002000
Abstract:
Methods are provided for providing anti-inflammatory activity and inhibiting a fibrotic disease, such as pulmonary fibrosis, in an individual. The methods comprise administering a biologically effective amount of latency-associated peptide (LAP) to the individual. Also provided are pharmaceutical compositions comprising LAP for use in accordance with these methods.
Diagnostic, Prognostic And Therapeutic Uses Of Mirs In Adaptive Pathways And/Or Disease Pathways
US Patent:
2011019, Aug 4, 2011
Filed:
Sep 18, 2009
Appl. No.:
13/119559
Inventors:
Clay B. Marsh - Columbus OH, US
Melissa G. Piper - Dublin OH, US
Duaa A. Dakhlallah - Columbus OH, US
Melissa G. Piper - Dublin OH, US
Duaa A. Dakhlallah - Columbus OH, US
Assignee:
THE OHIO STATE UNIVERSITY - Columbus OH
International Classification:
A61K 31/7105, C12Q 1/68, A61P 9/00, A61P 17/00
US Classification:
514 44 A, 435 613
Abstract:
Described herein are methods and compositions for the diagnosis, prognosis and treatment of various adaptive and/or of disease pathways by examining samples containing one or more miRs therein, and by formulating therapeutic agents therefrom.
Ets-2 Biomarkers For Fibrotic Diseases And Uses Thereof
US Patent:
2011028, Nov 17, 2011
Filed:
Jan 15, 2010
Appl. No.:
13/144578
Inventors:
Clay B. Marsh - Columbus OH, US
Christopher P. Baran - Hilliard OH, US
Christopher P. Baran - Hilliard OH, US
Assignee:
THE OHIO STATE UNIVERSITY - Columbus OH
International Classification:
A61K 39/395, C12Q 1/68, C40B 40/06, C40B 30/04, A61P 37/00, C07K 16/00, A61K 31/7105, A61K 31/711, A61K 38/02, G01N 33/566, C07K 14/00
US Classification:
4241301, 436501, 435 792, 435 612, 435 611, 506 16, 506 9, 530350, 5303891, 514 44 A, 514 44 R, 514 11
Abstract:
Methods and compositions for detecting, treating, characterizing, and diagnosing interstitial lung and/or fibrotic diseases are described.
Organic Compounds
US Patent:
2006005, Mar 9, 2006
Filed:
Jun 26, 2003
Appl. No.:
10/519654
Inventors:
Clay Marsh - Upper Arlington OH, US
International Classification:
A61K 31/496
US Classification:
514252180
Abstract:
4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2ylamino)phenyl]benzamide of the formula (I): or a pharmaceutically acceptable salt thereof for the treatment of inflammation.